Viewing Study NCT04373967


Ignite Creation Date: 2025-12-25 @ 12:53 AM
Ignite Modification Date: 2025-12-27 @ 10:28 PM
Study NCT ID: NCT04373967
Status: UNKNOWN
Last Update Posted: 2020-07-08
First Post: 2020-04-28
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study to Assess the Efficacy and Safety of Liraglutide in the Treatment of Type 2 Diabetes
Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: TQF2451-III-01
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators